Grey Matters Health Inc. (CSE: GREY) announced on November 16, 2026, that its flagship NovaScan Neuroimaging Clinics™ location in Davie, Florida has received accreditation and completed full enrollment in both U.S. Medicare and Medicaid programs. The company describes the milestone as a major step in its commercialisation pathway, enabling the clinic's brain-dedicated PET scanning services to be accessible to all eligible Americans enrolled in those programs. Investors may be watching closely as the development positions Grey Matters to begin billing under established codes for both brain PET scans and associated isotopes.

Key Points

  • Grey Matters Health Inc. (CSE: GREY, Frankfurt: AGW0, OTC: AGNPF) is a Canadian healthcare company focused on brain-dedicated PET scanning services.
  • The flagship NovaScan Neuroimaging Clinics™ location in Davie, Florida has received accreditation and completed Medicare and Medicaid enrollment.
  • The clinic, located at the HCA Florida University Medical Office Building, is described as the first U.S. facility offering brain-dedicated PET scans for Alzheimer's Disease detection.
  • Investors may watch for progress on private insurer in-network contract negotiations and the expansion of additional clinic locations.

What Accreditation Means for the NovaScan Neuroimaging Clinics™ Davie Location

Accreditation by a recognised U.S. governing body is a mandatory requirement for diagnostic imaging centres seeking Medicare reimbursement and in-network status with private insurers. The release states the review process evaluated radiation dose control, diagnostic image accuracy, and staff qualifications — including licensing and certifications of radiologists, medical physicists, and technologists. Grey Matters notes that accreditation signals to referring physicians that the centre will produce quality images, employ qualified personnel, and follow established patient safety protocols.

CareMiBrain™ Technology at the Heart of the Davie Clinic

The Davie location will feature the U.S. FDA-cleared CareMiBrain™ system, which the release describes as a dedicated brain PET scanner with a chair-styled design that does not require an integrated Computed Tomography component. According to the announcement, this design results in 25% less radiation exposure for patients. Brain PET scans for beta-amyloid plaque detection associated with Alzheimer's Disease are covered by Medicare, Medicaid, and most private insurance for patients aged 65 and older, the release states.

Grey Matters' U.S. Commercialisation Strategy for Brain PET Imaging

Grey Matters describes the Davie clinic as the first of its kind in the United States to provide brain-dedicated PET scans aimed at earlier detection of Alzheimer's Disease and other neurodegenerative conditions. CEO Christopher J. Moreau stated in the release that the company can now begin introducing doctors and patients to the clinic's features and technology, with a focus on advanced image resolution and an enhanced patient experience. The company's stated goal is to establish a chain of dedicated brain PET imaging clinics across the U.S., though no specific timelines or financial figures were disclosed in the announcement.